Overexpression of SASH1 in hepatocellular carcinoma cells was found to inhibit SHH, SMO, PTC, and GLI1 expression, thereby reducing proliferation, migration/invasion, and EMT progression [61]. This evidence concerns the gene GLI1 and hepatocellular carcinoma.